DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets | PR Newswire [Video]

New collaboration enhances Dario’s comprehensive GLP-1 offering with virtual physician management to meet growing demand from employers covering weight-loss medications, opening new revenue streams in direct-to-consumer and pharma channels

, /PRNewswire/ — January 14, 2025 — DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a leader in the global digital health market, today announced a collaboration with MediOrbis, a multi-specialty digital health provider, to add prescribing capabilities to Dario’s GLP-1 behavior change solution for a comprehensive medical weight loss program. This strategic addition creates a fully integrated solution for employers covering weight-loss medications and supports direct-to-consumer offerings, expanding Dario’s addressable market in one of the fastest-growing segments of digital health. 

Employer coverage of GLP-1 medications for weight loss continues to grow, with a recent survey from Mercer showing 44% of large employers now covering obesity drugs.[1] As more employers cover obesity medications, the rising costs of these drugs highlight the need for strategic plan designs that ensure …